Transcripts SynAct Pharma AB

Stocks

Market Closed - Nasdaq Stockholm 20:00:00 28/09/2026 +04			5-day change	1st Jan Change
17.68 ^SEK	+2.20%		-1.23%	-21.77%

09-16	Synact Pharma's resomelagon highlighted by WHO for dengue fever	FW
09-16	SynAct Pharma Identifies Resomelagon As One Of Six Dengue Drug Candidates With Evidence Supporting Further Clinical Development	CI

06-15	SynAct Pharma AB - Special Call
03-11	SynAct Pharma AB - Analyst/Investor Day
04/06/25	SynAct Pharma AB - Analyst/Investor Day

No results match your criteria